A2M and liver dysplastic nodule: The concentration of α2-M in the serum of patients with DN is significantly higher than that of healthy people (1.52 ± 0.43 mg∙mL−1), so α2-M can be used as an important biomarker for the early diagnosis and prediction of DN.